244 related articles for article (PubMed ID: 20179793)
21. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
22. A Search for Causes of Rising Incidence of Differentiated Thyroid Cancer in Children and Adolescents after Chernobyl and Fukushima: Comparison of the Clinical Features and Their Relevance for Treatment and Prognosis.
Drozd V; Saenko V; Branovan DI; Brown K; Yamashita S; Reiners C
Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33810323
[TBL] [Abstract][Full Text] [Related]
23. Thyroglobulin measurement in differentiated thyroid carcinoma management.
Giovanella L
Expert Rev Endocrinol Metab; 2008 Mar; 3(2):117-125. PubMed ID: 30764086
[TBL] [Abstract][Full Text] [Related]
24. Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications.
Van Nostrand D
Thyroid; 2018 Sep; 28(9):1083-1093. PubMed ID: 30105931
[TBL] [Abstract][Full Text] [Related]
25. Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer.
Mu ZZ; Zhang X; Lin YS
Chonnam Med J; 2019 Sep; 55(3):127-135. PubMed ID: 31598469
[TBL] [Abstract][Full Text] [Related]
26. Pediatric papillary thyroid cancer: current management challenges.
Verburg FA; Van Santen HM; Luster M
Onco Targets Ther; 2017; 10():165-175. PubMed ID: 28096684
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study.
Kathuria-Prakash N; Mosaferi T; Xie M; Antrim L; Angell TE; In GK; Su MA; Lechner MG
Endocr Pract; 2021 Feb; 27(2):90-94. PubMed ID: 33551317
[TBL] [Abstract][Full Text] [Related]
28. Management of Differentiated Thyroid Cancer in Children: Focus on the American Thyroid Association Pediatric Guidelines.
Parisi MT; Eslamy H; Mankoff D
Semin Nucl Med; 2016 Mar; 46(2):147-64. PubMed ID: 26897719
[TBL] [Abstract][Full Text] [Related]
29. Trends in pediatric thyroid cancer incidence in the United States, 1998-2013.
Bernier MO; Withrow DR; Berrington de Gonzalez A; Lam CJK; Linet MS; Kitahara CM; Shiels MS
Cancer; 2019 Jul; 125(14):2497-2505. PubMed ID: 31012956
[TBL] [Abstract][Full Text] [Related]
30. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.
Schlumberger M; Berg G; Cohen O; Duntas L; Jamar F; Jarzab B; Limbert E; Lind P; Pacini F; Reiners C; Sánchez Franco F; Toft A; Wiersinga WM
Eur J Endocrinol; 2004 Feb; 150(2):105-12. PubMed ID: 14763906
[TBL] [Abstract][Full Text] [Related]
31. Patterns of differentiated thyroid cancer in Baluchistan Province of Pakistan: some initial observations.
Iftikhar A; Naseeb AK; Khwaja A; Mati H; Karim K; Hameeda N
Med J Malaysia; 2011 Oct; 66(4):322-5. PubMed ID: 22299551
[TBL] [Abstract][Full Text] [Related]
32. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
Haugen BR
Cancer; 2017 Feb; 123(3):372-381. PubMed ID: 27741354
[TBL] [Abstract][Full Text] [Related]
33. A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma.
Giusti M; Sibilla F; Cappi C; Dellepiane M; Tombesi F; Ceresola E; Augeri C; Rasore E; Minuto F
J Endocrinol Invest; 2005; 28(7):599-608. PubMed ID: 16218042
[TBL] [Abstract][Full Text] [Related]
34. Differentiated thyroid cancer theranostics: radioiodine and beyond.
Choudhury PS; Gupta M
Br J Radiol; 2018 Nov; 91(1091):20180136. PubMed ID: 30260232
[TBL] [Abstract][Full Text] [Related]
35. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
[TBL] [Abstract][Full Text] [Related]
36. Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI).
Capdevila J; Galofré JC; Grande E; Zafón Llopis C; Ramón Y Cajal Asensio T; Navarro González E; Jiménez-Fonseca P; Santamaría Sandi J; Gómez Sáez JM; Riesco Eizaguirre G
Clin Transl Oncol; 2017 Mar; 19(3):279-287. PubMed ID: 27704399
[TBL] [Abstract][Full Text] [Related]
37. [Management and dynamic risk stratification of differentiated thyroid cancer].
Huang YC; Li ZJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 54(5):389-393. PubMed ID: 31137103
[TBL] [Abstract][Full Text] [Related]
38. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
[TBL] [Abstract][Full Text] [Related]
39. Differentiated thyroid carcinoma: defining new paradigms for postoperative management.
Durante C; Costante G; Filetti S
Endocr Relat Cancer; 2013 Aug; 20(4):R141-54. PubMed ID: 23572163
[TBL] [Abstract][Full Text] [Related]
40. Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer.
Adjadj E; Schlumberger M; de Vathaire F
Lancet Oncol; 2009 Feb; 10(2):181-90. PubMed ID: 19185836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
